We are looking for a Clinical Trial Lead to continue ongoing management and completion of the REBUILD-SM trial.
The REBUILD-SM trial is addressing a major unmet need identified by people with interstitial lung disease (ILD), for disease-specific self-management and support.
This randomised clinical trial studies the efficacy and cost-effectiveness of our self-management program delivered via a smartphone application.
The aim of the work is to improve quality of life for people living with ILD, through better self-efficacy and reduced symptom burden and anxiety.
Join our awesome team and make a difference for people living with interstitial lung disease.